COVID-19: Vaccines and Therapeutics
In a study reported yesterday in JAMA Internal Medicine, children and adolescents previously diagnosed with multisystem inflammatory syndrome (MIS-C) reported no serious complications after COVID-19 vaccination.
A COVID-19 bivalent vaccine booster provides additional protection against COVID-19鈥揳ssociated emergency department/urgent care encounters and hospitalizations compared with previous vaccination with two or more monovalent vaccine doses, according to studies in adults and older adults released鈥
Fewer than 1 in 4 pediatric hospital beds are available nationwide, according to data from the U.S. Department of Health and Human Services. A pediatric infectious disease physician at Lurie Children鈥檚 Hospital in Chicago talks about the growing risks of infectious diseases, such as COVID-19, and鈥
An animated video course describes seven distinct vaccine-related mindsets, or personas, and models how health care professionals can apply person-centered communication strategies when discussing COVID-19 vaccination. The online course, created by the Stanford Center for Continuing Medical鈥
Two healthy children overcame severe illness due to COVID-19, receiving care and treatment at Texas Children鈥檚 Hospital in Houston. Both children had developed MIS-C, a rare but serious condition associated with COVID-19. Texas Children鈥檚 has released a video of the parents sharing their stories 鈥斺
Lucile Packard Children鈥檚 Hospital Stanford, part of the Stanford Medicine Children鈥檚 Health Network, is at 鈥渓evel 3 alert鈥 capacity rate due to the triple threat of COVID-19, RSV and the flu. That鈥檚 one step away of putting tents outside the hospital鈥檚 front doors. Health officials say getting鈥
The Centers for Disease Control and Prevention today recommended the Moderna and Pfizer bivalent COVID-19 vaccines in children as young as 6 months old.
The Food and Drug Administration today authorized the Moderna and Pfizer bivalent COVID-19 vaccines for emergency use in children as young as 6 months old. Specifically, the agency authorized the Moderna vaccine as a single booster dose for children aged 6 months through 5 at least two months after鈥
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., today encouraged all eligible Americans to get vaccinated against the flu and COVID-19, noting that hospitals continue to experience the highest flu admissions in a decade this early in the season.
The Food and Drug Administration does not currently authorize the monoclonal antibody bamlanivimab for emergency use to treat mild-to-moderate COVID-19 in the United States because it is not expected to neutralize the predominating BQ.1 and BQ.1.1. omicron subvariants.